136 related articles for article (PubMed ID: 8089927)
21. Continuously applied compressive pressure induces bone resorption by a mechanism involving prostaglandin E2 synthesis.
Imamura K; Ozawa H; Hiraide T; Takahashi N; Shibasaki Y; Fukuhara T; Suda T
J Cell Physiol; 1990 Aug; 144(2):222-8. PubMed ID: 2166056
[TBL] [Abstract][Full Text] [Related]
22. An assay system utilizing devitalized bone for assessment of differentiation of osteoclast progenitors.
Amano S; Hanazawa S; Kawata Y; Ohta K; Kitami H; Kitano S
J Bone Miner Res; 1992 Mar; 7(3):321-8. PubMed ID: 1585834
[TBL] [Abstract][Full Text] [Related]
23. Role of prostaglandin in the formation of osteoclasts induced by capsular-like polysaccharide antigen of Actinobacillus actinomycetemcomitans strain Y4.
Ueda N; Nishihara T; Ishihara Y; Amano K; Kuroyanagi T; Noguchi T
Oral Microbiol Immunol; 1995 Apr; 10(2):69-75. PubMed ID: 7675521
[TBL] [Abstract][Full Text] [Related]
24. The bone marrow-derived stromal cell lines MC3T3-G2/PA6 and ST2 support osteoclast-like cell differentiation in cocultures with mouse spleen cells.
Udagawa N; Takahashi N; Akatsu T; Sasaki T; Yamaguchi A; Kodama H; Martin TJ; Suda T
Endocrinology; 1989 Oct; 125(4):1805-13. PubMed ID: 2676473
[TBL] [Abstract][Full Text] [Related]
25. Differential effects of transforming growth factor-beta on osteoclast-like cell formation in mouse marrow culture: relation to the effect of zinc-chelating dipeptides.
Yamaguchi M; Kishi S
Peptides; 1995; 16(8):1483-8. PubMed ID: 8745062
[TBL] [Abstract][Full Text] [Related]
26. SC-19220, a prostaglandin E2 antagonist, inhibits osteoclast formation by 1,25-dihydroxyvitamin D3 in cell cultures.
Inoue H; Tsujisawa T; Fukuizumi T; Kawagishi S; Uchiyama C
J Endocrinol; 1999 May; 161(2):231-6. PubMed ID: 10320820
[TBL] [Abstract][Full Text] [Related]
27. Development and characterization of a porcine model to study osteoclast differentiation and activity.
Galvin RJ; Bryan P; Horn JW; Rippy MK; Thomas JE
Bone; 1996 Sep; 19(3):271-9. PubMed ID: 8873968
[TBL] [Abstract][Full Text] [Related]
28. Basic fibroblast growth factor induces osteoclast formation in murine bone marrow cultures.
Hurley MM; Lee SK; Raisz LG; Bernecker P; Lorenzo J
Bone; 1998 Apr; 22(4):309-16. PubMed ID: 9556129
[TBL] [Abstract][Full Text] [Related]
29. Inhibitory effect of ipriflavone on osteoclast-mediated bone resorption and new osteoclast formation in long-term cultures of mouse unfractionated bone cells.
Notoya K; Yoshida K; Taketomi S; Yamazaki I; Kumegawa M
Calcif Tissue Int; 1993 Sep; 53(3):206-9. PubMed ID: 8242474
[TBL] [Abstract][Full Text] [Related]
30. Generation of osteoclastic function in mouse bone marrow cultures: multinuclearity and tartrate-resistant acid phosphatase are unreliable markers for osteoclastic differentiation.
Hattersley G; Chambers TJ
Endocrinology; 1989 Apr; 124(4):1689-96. PubMed ID: 2924719
[TBL] [Abstract][Full Text] [Related]
31. Phorbol myristate acetate stimulates osteoclast formation in 1 alpha,25-dihydroxyvitamin D3-primed mouse embryonic calvarial cells by a prostaglandin-dependent mechanism.
Amano S; Hanazawa S; Kawata Y; Nakada Y; Miyata Y; Kitano S
J Bone Miner Res; 1994 Apr; 9(4):465-72. PubMed ID: 8030434
[TBL] [Abstract][Full Text] [Related]
32. Short treatment of osteoclasts in bone marrow culture with calcitonin causes prolonged suppression of calcitonin receptor mRNA.
Rakopoulos M; Ikegame M; Findlay DM; Martin TJ; Moseley JM
Bone; 1995 Nov; 17(5):447-53. PubMed ID: 8579955
[TBL] [Abstract][Full Text] [Related]
33. Osteoblasts mediate insulin-like growth factor-I and -II stimulation of osteoclast formation and function.
Hill PA; Reynolds JJ; Meikle MC
Endocrinology; 1995 Jan; 136(1):124-31. PubMed ID: 7828521
[TBL] [Abstract][Full Text] [Related]
34. Interleukin-6 does not mediate the stimulation by prostaglandin E2, parathyroid hormone, or 1,25 dihydroxyvitamin D3 of osteoclast differentiation and bone resorption in neonatal mouse parietal bones.
Holt I; Davie MW; Braidman IP; Marshall MJ
Calcif Tissue Int; 1994 Aug; 55(2):114-9. PubMed ID: 7953976
[TBL] [Abstract][Full Text] [Related]
35. Osteoclast differentiation in cocultures of a clonal chondrogenic cell line and mouse bone marrow cells.
Taylor LM; Turksen K; Aubin JE; Heersche JN
Endocrinology; 1993 Nov; 133(5):2292-300. PubMed ID: 7691585
[TBL] [Abstract][Full Text] [Related]
36. Characterization of zinc effect to inhibit osteoclast-like cell formation in mouse marrow culture: interaction with dexamethasone.
Kishi S; Yamaguchi M
Mol Cell Biochem; 1997 Jan; 166(1-2):145-51. PubMed ID: 9046031
[TBL] [Abstract][Full Text] [Related]
37. Inhibitory effect of zinc compounds on osteoclast-like cell formation in mouse marrow cultures.
Kishi S; Yamaguchi M
Biochem Pharmacol; 1994 Sep; 48(6):1225-30. PubMed ID: 7945416
[TBL] [Abstract][Full Text] [Related]
38. Thiazolidinediones inhibit osteoclast-like cell formation and bone resorption in vitro.
Okazaki R; Toriumi M; Fukumoto S; Miyamoto M; Fujita T; Tanaka K; Takeuchi Y
Endocrinology; 1999 Nov; 140(11):5060-5. PubMed ID: 10537132
[TBL] [Abstract][Full Text] [Related]
39. Macrophage colony-stimulating factor and interleukin-1 alpha maintain the survival of osteoclast-like cells.
Jimi E; Shuto T; Koga T
Endocrinology; 1995 Feb; 136(2):808-11. PubMed ID: 7835314
[TBL] [Abstract][Full Text] [Related]
40. Prostaglandin E2 initially inhibits and then stimulates bone resorption in isolated rabbit osteoclast cultures.
Okuda A; Taylor LM; Heersche JN
Bone Miner; 1989 Nov; 7(3):255-66. PubMed ID: 2558751
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
